Balveen Kaur

Augusta University

NIH Rank #8314
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#8,314
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 4 grants · National rank #8314.

Top grants by award amount

Balveen Kaur's NIH grant portfolio, ranked by award amount.

  • 1R01NS137577-01R01
    Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma
    $563.9K
    award amount
  • 5R01NS127473-03R01
    Next Gen Virotherapy for GBM
    $513.7K
    award amount
  • 1R61NS128191-01A1R61
    Development of murine glioblastoma model for oncolytic HSV therapy
    $395.8K
    award amount
  • 5P01CA163205-12P01
    Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
    $62K
    award amount

Affiliations

Institutions that have administered grants for Balveen Kaur.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Augusta University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8314
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions